Ultimaster Nagomi™

Improved Stent Design^4.5

• 3 platforms specifically designed to meet the needs of each vessel size^4,5
• Strut & band width shortened to help increase flexibility (for Ø2.00mm to Ø2.50mm stents)^4-6
• New 10-crown design in the large vessel :
  • to ensure better apposition even in large bifurcations, including left main trunk^4,5,7
  • allows a better expansion capability with a uniform vessel coverage compared to an 8-crown design^4,5,8,9

Larger Size Line-up¹¹

• The largest size line-up in the Ultimaster Family, from Φ2.00 to Φ4.50mm and 9 to 50mmlength to treat a broader range of lesions^4,5,8
• New 44 & 50m lengths, for optimal sizing in long lesions^4,5

Greater Overexpansion Capability¹¹

• 10-crown design for a better expansion in large vessels^4,5,8
• Optimized overexpansion capability, up to 6.25 mm (for Ø3.50mm to Ø4.50mm stents)⁸

Excellent Deliverability¹¹

• New hydrophilic coating for enhanced deliverability^10,11
• New balloon with a nominal pressure of 11 atm for a better apposition^7,12
• Increased catheter inner lumen for fast deflation time^13,14

Inherited Drug and Polymer

Inherited abluminal gradient bioresorbable coating to maintain polymer integrity even when overexpanded, allowing for an optimized drug dose of sirolimus (3.9 μg/mm of stent)4,5,15,16, simultaneous polymer resorption and drug release within 3-4 months.

Ultimaster Nagomi™ is building on the Heritage of Strong Clinical Evidence of the Ultimaster™ Stent Family²²

• 50,000 patients enrolled in the Ultimaster™ clinical program, covering the most complex patient subgroups¹⁷ :
  • Optimal vascular repair¹⁸
  • Long term safety and efficacy in RCT mirrored in real world clinical practice^19,20
  • 1-month DAPT in high-bleeding risk patients²¹